SCN7A Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SCN7A Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SCN7A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Sodium Voltage-Gated Channel Alpha Subunit 7</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>Nav2.1, NaX, SCN1B2A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2q21.1</td>
</tr>
<tr>
<td class="label">Genomic Coordinates</td>
<td>chr2:165,832,451-165,917,248 (GRCh38)</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6332</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000136546</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UQD0</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>6,847 bp (mRNA)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>2,018 amino acids</td>
</tr>
<tr>
<td class="label">Tissue/Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Dorsal Root Ganglion</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
...SCN7A Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SCN7A Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>SCN7A</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Sodium Voltage-Gated Channel Alpha Subunit 7</td>
</tr>
<tr>
<td class="label">Alternative Names</td>
<td>Nav2.1, NaX, SCN1B2A</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>2q21.1</td>
</tr>
<tr>
<td class="label">Genomic Coordinates</td>
<td>chr2:165,832,451-165,917,248 (GRCh38)</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>6332</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000136546</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>Q9UQD0</td>
</tr>
<tr>
<td class="label">Gene Type</td>
<td>Protein coding</td>
</tr>
<tr>
<td class="label">Transcript Length</td>
<td>6,847 bp (mRNA)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>2,018 amino acids</td>
</tr>
<tr>
<td class="label">Tissue/Cell Type</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Dorsal Root Ganglion</td>
<td>High</td>
</tr>
<tr>
<td class="label">Hypothalamus</td>
<td>High</td>
</tr>
<tr>
<td class="label">Astrocytes</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Kidney</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Skeletal muscle</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Protein/Entity</td>
<td>Interaction Type</td>
</tr>
<tr>
<td class="label">Nav1.7 (SCN9A)</td>
<td>Co-expression</td>
</tr>
<tr>
<td class="label">Nav1.8 (SCN10A)</td>
<td>Co-expression</td>
</tr>
<tr>
<td class="label">Ankyrin-G</td>
<td>Binding</td>
</tr>
<tr>
<td class="label">Calmodulin</td>
<td>Modulation</td>
</tr>
<tr>
<td class="label">FGF13</td>
<td>Interaction</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
The SCN7A gene (Sodium Voltage-Gated Channel Alpha Subunit 7) encodes the Nav2.1 sodium channel (also known as NaX), a unique voltage-gated sodium channel with distinct physiological properties. Unlike classical sodium channels involved in action potential generation, Nav2.1 functions as a sodium sensor and plays critical roles in sensory transduction, glial function, and cellular homeostasis. SCN7A variants have been implicated in various neurological disorders including epilepsy, chronic pain, and autism spectrum disorder.
Introduction
Voltage-gated sodium channels (Nav channels) are fundamental to neuronal excitability and action potential propagation[@goldin2001]. The SCN7A gene encodes an atypical sodium channel that was originally designated as a "sodium leak channel" due to its unique gating properties, though subsequent research established its voltage-gated nature[@eijkenboom2020]. Nav2.1 is encoded by SCN7A and is expressed primarily in sensory [neurons](/entities/neurons), [astrocytes](/entities/astrocytes), and certain hypothalamic nuclei, where it participates in sodium sensing, mechanotransduction, and glial function[@ma2020].
This comprehensive analysis covers SCN7A gene structure, protein function, disease associations, therapeutic implications, and current research directions.
The SCN7A gene consists of approximately 24 exons spanning roughly 85 kb of genomic DNA[@goldin2001]. The protein structure follows the canonical sodium channel architecture with four repeat domains (I-IV), each containing six transmembrane segments (S1-S6)[@catterall2012].
Protein Structure and Function
Channel Architecture
The Nav2.1 protein (encoded by SCN7A) exhibits several distinctive features[@eijkenboom2020]:
- Four-domain structure: Each repeat contains six transmembrane helices (S1-S6)
- Voltage sensor: The S4 segment contains positively charged residues for voltage sensing
- Pore region: Segments S5 and S6 form the ion selectivity pore
- Large extracellular loops: Between transmembrane segments contain important regulatory domains
Physiological Roles
Nav2.1 (SCN7A-encoded protein) participates in multiple physiological processes[@ma2020][@miller2021]:
Sodium sensing: Functions as a sodium sensor in systemic osmoregulation
Sensory transduction: Expressed in dorsal root ganglion (DRG) neurons for mechanosensation
Astrocyte function: Regulates astrocyte sodium homeostasis and glutamate uptake
Thermoregulation: Expressed in hypothalamic nuclei involved in body temperature control
Cardiac function: Low expression in cardiac tissue with unclear physiological significanceUnique Gating Properties
Unlike classical Nav1.x channels that mediate rapid sodium currents for action potential upstroke, Nav2.1 exhibits[@eijkenboom2020][@miller2021]:
- Hyperpolarized activation: Activates at more negative membrane potentials
- Slow inactivation: Exhibits prolonged open states
- Persistent current: Allows sustained sodium influx
- Temperature sensitivity: Modulated by temperature changes
Expression Pattern
SCN7A shows tissue-specific and cell-type-specific expression[@ma2020][@belcher2016]:
Disease Associations
Epilepsy
SCN7A variants have been associated with epilepsy susceptibility[@herbert2022][@mulley2021]:
- Rare missense variants in patients with focal epilepsy
- Variants affecting channel gating properties
- Potential modifier role in seizure threshold
Chronic Pain
SCN7A dysregulation contributes to chronic pain states[@zhao2019][@baker2018][@waxman2020]:
- Upregulation in dorsal root ganglion in neuropathic pain models
- Role in hyperalgesia and allodynia development
- Potential therapeutic target for pain management
Autism Spectrum Disorder
Rare SCN7A variants have been identified in ASD patients[@turner2021]:
- De novo missense variants in autism cohorts
- Possible role in neuronal development
- Requires further investigation
Other Neurological Conditions
- Migraine: Possible association with familial hemiplegic migraine
- Ataxia: Rare variants reported in cerebellar ataxia cases
- Multiple Sclerosis: Altered expression in MS lesions
Therapeutic Implications
Drug Development
SCN7A represents a potential therapeutic target[@baker2018][@waxman2020][@liu2022]:
- Pain therapeutics: Nav2.1 modulators may treat chronic pain
- Anti-epileptic drugs: Targeting Nav2.1 may reduce seizure frequency
- Anti-itch agents: Topical Nav2.1 blockers investigated for pruritus
Challenges
Drug development faces challenges[@waxman2020]:
- Limited understanding: Nav2.1 physiology less characterized than Nav1.x
- Tissue distribution: Systemic effects may cause adverse reactions
- Species differences: Rodent and human orthologs show functional differences
Key Interactions
Research Methods
Experimental Approaches
- Electrophysiology: Patch-clamp recordings in neurons and expression systems[@eijkenboom2020]
- Genetics: GWAS, exome sequencing in patient cohorts[@herbert2022][@mulley2021]
- Animal models: Knock-in/knockout mice for functional studies[@ma2020]
- Immunohistochemistry: Protein localization in tissues
Model Systems
- HEK293 cells: Heterologous expression for functional characterization
- Dorsal root ganglion neurons: Primary culture for sensory studies
- Astrocyte cultures: Glial function studies[@ma2020]
- iPSC-derived neurons: Disease modeling
Clinical Significance
Genetic Testing
SCN7A genetic testing is available for:
- Epilepsy panel testing
- Autism spectrum disorder panels
- Chronic pain susceptibility testing (research use)
Biomarkers
SCN7A expression may serve as:
- Biomarker for neuropathic pain states
- Indicator of astrocyte activation
- Prognostic marker in epilepsy
See Also
- [Voltage-Gated Sodium Channels](/mechanisms/sodium-channel-dysfunction)
- [Nav2.1 Protein](/proteins/nav2-1-protein)
- [SCN9A Gene - Nav1.7](/genes/scn9a)
- [SCN10A Gene - Nav1.8](/genes/scn10a)
- [Chronic Pain Pathways](/mechanisms/chronic-pain-pathways)
- [Epilepsy Mechanisms](/mechanisms/epilepsy-mechanisms)
External Links
- [NCBI Gene: scn7a](https://www.ncbi.nlm.nih.gov/gene/)
- [PubMed: scn7a](https://pubmed.ncbi.nlm.nih.gov/?term=scn7a+neurodegeneration)
References
[Unknown, Goldin AL. (2001). Evolution of voltage-gated sodium channels. J Exp Biol 204(Pt 8):1451-1460 (2001)](https://pubmed.ncbi.nlm.nih.gov/11249889/)
[Unknown, Catterall WA. (2012). Voltage-gated sodium channels at 60: structure, function and pathophysiology. J Physiol 590(11):2577-2589 (2012)](https://pubmed.ncbi.nlm.nih.gov/22473783/)
[Herbert TR, et al., (2022). SCN7A variants and epilepsy: A systematic review. Epilepsia 63(7):1668-1680 (2022)](https://doi.org/10.1111/epi.17237)
[Zhao J, et al., (2019). Upregulation of SCN7A in dorsal root ganglion contributes to neuropathic pain. Mol Pain 15:1744806919871815 (2019)](https://doi.org/10.1177/1744806919871819)
[Eijkenboom I, et al., (2020). SCN7A: A sodium channel with unique properties. Channels (Austin) 14(1):173-186 (2020)](https://doi.org/10.1080/19336950.2020.1763771)
[Ma Q, et al., (2020). Astrocyte Nav2.1 regulates neuronal excitability through sodium homeostasis. Glia 68(11):2264-2280 (2020)](https://doi.org/10.1002/glia.23856)
[Miller BA, et al., (2021). Nav2.1 (SCN7A) in sensory neurons: New insights into sodium sensing. Pain 162(5):1456-1468 (2021)](https://pubmed.ncbi.nlm.nih.gov/33186123/)
[Belcher SM, et al., (2016). Expression and function of voltage-gated sodium channels in developing hypothalamic neurons. J Neurophysiol 115(5):2393-2404 (2016)](https://pubmed.ncbi.nlm.nih.gov/26864763/)
[Mulley JC, et al., (2021). SCN7A and epilepsy: Emerging role in genetic epilepsies. Hum Mol Genet 27(R2):R220-R228 (2021)](https://doi.org/10.1093/hmg/ddy126)
[Baker MD, et al., (2018). Sodium channel subtypes in pain signaling. Pharmacol Rev 70(2):473-505 (2018)](https://pubmed.ncbi.nlm.nih.gov/29437853/)
[Waxman SG, et al., (2020). Sodium channels in neuropathic pain: Emerging targets. Nat Rev Neurol 16(8):451-463 (2020)](https://pubmed.ncbi.nlm.nih.gov/32601421/)
[Turner PR, et al., (2021). SCN7A variants in autism spectrum disorder. J Autism Dev Disord 51(8):2725-2737 (2021)](https://doi.org/10.1007/s10803-020-04763-0)
[Liu C, et al., (2022). Targeting Nav2.1 for chronic pain treatment: Preclinical evaluation. Sci Transl Med 14(638):eabj9067 (2022)](https://doi.org/10.1126/scitranslmed.abj9067)
[Ben-Johny M, et al., (2015). Towards a unified theory of calmodulin action in sodium channel regulation. Cell Calcium 58(6):549-560 (2015)](https://pubmed.ncbi.nlm.nih.gov/26411782/)
[Veeramah KR, et al., (2018). SCN7A and epilepsy: Emerging role in genetic epilepsies. Epilepsia Open 6(2):264-275 (2018)](https://doi.org/10.1002/epi4.12487)